Cytosorbents Corp — Director's Dealing 2013

Feb 13, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2012-12-31

Reporting Person: BERGER RONALD (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-08-11	Common Stock, par value $0.001 per share	P	500	$3.72	Acquired	6500	Indirect
2007-06-21	Common Stock, par value $0.001 per share	P	1000	$0.55	Acquired	6500	Indirect
2007-08-27	Common Stock, par value $0.001 per share	P	5000	$0.55	Acquired	6500	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-10-05	Series B Preferred Stock	$0.0362	P	68.83	Acquired		Common Stock, par value $0.001 per share (190138)	Direct
2010-10-22	Convertible Note	$0.10	P		Acquired	2012-10-22	Common Stock, par value $0.001 (58011)	Direct
2010-10-22	Warrants	$	P	43333	Acquired		Common Stock, par value $0.001 (43333)	Direct
2010-01-04	Stock Options	$0.173	A	15000	Acquired	2015-01-04	Common Stock, par value $0.001 per share (15000)	Direct
2009-01-28	Stock Options	$0.168	A	15000	Acquired	2014-01-28	Common Stock, par value $0.001 per share (15000)	Direct
2012-01-18	Stock Options	$0.168	A	30000	Acquired	2017-01-18	Common Stock, par value $0.001 per share (30000)	Direct
2008-01-16	Stock Options	$0.25	A	9000	Acquired	2013-01-16	Common Stock, par value $0.001 per share (9000)	Direct
2011-01-06	Stock Options	$0.136	A	75000	Acquired	2016-01-06	Common Stock, par value $0.001 per share (75000)	Direct
2008-06-25	Stock Options	$0.035	A	9000	Acquired	2013-06-25	Common Stock, par value $0.001 per share (9000)	Direct

Footnotes

F1: The conversation rate of these securities is one share of the Issuer's Common Stock for each $0.0362 of stated value or accrued but unpaid dividends being converted, subject to adjustment. Each share of the Series B Preferred Stock has a stated value of $100.

F2: Immediately exercisable.

F3: Not applicable.

F4: The convertible note has expired as of October 22, 2012. Accordingly, the note is convertible into 58,011 shares of Common Stock (the aggregate amount of principal plus accrued interest) at maturity. The Company has not yet issued the corresponding shares, however, intends to do so promptly.

F5: In connection with the Convertible Note, Ronald Berger holds the following warrants: (i) 8,333 warrants with an exercise price of $0.15, (ii) 10,000 warrants with an exercise price of $0.125, and (iii) 25,000 warrants with an exercise price of $0.10.

F6: The stock options were issued as compensation for services rendered.

F7: Includes all of the options to purchase Common Stock by Ronald Berger.